Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 31 AL 45

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

Majláth Z, Török N, Toldi J, Vécsei L.

Curr Neuropharmacol. 2016;14(2):200-9. doi: 10.2174/1570159x14666151113123221.

Brain local and regional neuroglial alterations in Alzheimer's Disease: cell types, responses and implications

Toledano A, Álvarez MI, Toledano-Díaz A, Merino JJ, Rodríguez JJ.

Curr Alzheimer Res. 2016;13(4):321-42. doi: 10.2174/1567205013666151116141217.

Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease

Lim D, Rodríguez-Arellano JJ, Parpura V, Zorec R, Zeidán-Chuliá F, Genazzani AA, Verkhratsky A.

Curr Alzheimer Res. 2016;13(4):359-69. doi: 10.2174/1567205013666151116130104.

Microglia in Alzheimer's disease: the good, the bad and the ugly

Tejera D, Heneka MT.

Curr Alzheimer Res. 2016;13(4):370-80. doi: 10.2174/1567205013666151116125012.

Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways

Esteras N, Alquézar C, de la Encarnación A, Martín-Requero Á.

Curr Alzheimer Res. 2016;13(4):439-49. doi: 10.2174/1567205013666151116124912.

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

Novak G, Fox N, Clegg S, Nielsen C, Einstein S, Lu Y, Tudor IC, Gregg K, Di J, Collins P, Wyman BT, Yuen E, Grundman M, Brashear HR, Liu E.

J Alzheimers Dis. 2016;49(4):1123-34. doi: 10.3233/JAD-150448.

Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine

Carrera I, Fernandez-Novoa L, Aliev G, Vigo C, Cacabelos R.

Curr Pharm Des. 2016;22(7):849-58. doi: 10.2174/1381612822666151209152204.

Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease

Potter H, Granic A, Caneus J.

Curr Alzheimer Res. 2016;13(1):7-17. doi: 10.2174/156720501301151207100616.

Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies

Avila J, Pallas N, Bolós M, Sayas CL, Hernandez F.

Expert Opin Ther Targets. 2016 Jun;20(6):653-61. doi: 10.1517/14728222.2016.1131269. Epub 2016 Feb 16.

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease

Bu XL, Jiao SS, Lian Y, Wang YJ.

Curr Alzheimer Res. 2016;13(3):307-16. doi: 10.2174/1567205013666151215110114.

Defining the earliest pathological changes of Alzheimer's disease

Vickers JC, Mitew S, Woodhouse A, Fernandez-Martos CM, Kirkcaldie MT, Canty AJ, McCormack GH, King AE.

Curr Alzheimer Res. 2016;13(3):281-7. doi: 10.2174/1567205013666151218150322.

Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease

Chakrabarti M, McDonald AJ, Will Reed J, Moss MA, Das BC, Ray SK.

J Alzheimers Dis. 2016;50(2):335-52. doi: 10.3233/JAD-150450.

Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review

Gardener SL, Rainey-Smith SR, Martins RN.

J Alzheimers Dis. 2016;50(2):301-34. doi: 10.3233/JAD-150765.

Home Modifications for People With Alzheimer's Disease: A Scoping Review

Struckmeyer LR, Pickens ND.

Am J Occup Ther. 2016 Jan-Feb;70(1):7001270020p1-9. doi: 10.5014/ajot.2015.016089.

Molecular links between early energy metabolism alterations and Alzheimer's disease

Pedros I, Patraca I, Martinez N, Petrov D, Sureda FX, Auladell C, Beas-Zarate C, Folch J.

Front Biosci (Landmark Ed). 2016 Jan 1;21(1):8-19. doi: 10.2741/4372.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias